Factors affecting decision making at reassessment of periodontitis. Part 2: interpretation of clinical findings - systemic factors


This paper is the second in a four-part series outlining treatment planning at periodontal reassessment. The first article focussed on the information that should be gathered at the reassessment appointment. Treatment can involve a range of non-surgical and surgical approaches. A variety of general, practical and local site factors can affect the choice of one option over another in choosing the most predictable treatment option. Residual periodontal probing depths can be associated with both systemic and local factors. This article (part 2) outlines systemic factors that need to be assessed when faced with residual periodontal probing depths.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Armitage G C, Xenoudi P. Post-treatment supportive care for the natural dentition and dental implants. Periodontol 2000 2016; 71: 164-184.

  2. 2.

    Axelsson P, Lindhe J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. Results after 6 years. J Clin Periodontol 1981; 8: 239-248.

  3. 3.

    Axelsson P N B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol 2004; 31: 749-757.

  4. 4.

    Rosling B, Serino G, Hellstrom M K, Socransky S S, Lindhe J. Longitudinal periodontal tissue alterations during supportive therapy. Findings from subjects with normal and high susceptibility to periodontal disease. J Clin Periodontol 2001; 28: 241-249.

  5. 5.

    Matuliene G, Pjetursson B E, Salvi G E et al. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol 2008; 35: 685-695.

  6. 6.

    Lang N P, Tonetti M S. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent 2003; 1: 7-16.

  7. 7.

    Jepsen S, Caton J G, Albandar J M et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 2018; 89 (Suppl 1): S237s248.

  8. 8.

    Albandar J M, Susin C, Hughes F J. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J Periodontol 2018; 89 (Suppl 1): S183s203.

  9. 9.

    Ramseier C A, Warnakulasuriya S, Needleman I G et al. Consensus Report: 2nd European Workshop on Tobacco Use Prevention and Cessation for Oral Health Professionals. Int Dent J 2010; 60: 3-6.

  10. 10.

    WHO monograph on tobacco cessation and oral health integration. World Health Organization, 2017.

  11. 11.

    Ryder M I, Couch E T, Chaffee B W. Personalized periodontal treatment for the tobaccoand alcohol-using patient. Periodontol 2000 2018; 78: 30-46.

  12. 12.

    Johnson G K, Guthmiller J M. The impact of cigarette smoking on periodontal disease and treatment. Periodontol 2000 2007; 44: 178-194.

  13. 13.

    Nociti F H, Jr, Casati M Z, Duarte P M. Current perspective of the impact of smoking on the progression and treatment of periodontitis. Periodontol 2000-2015; 67: 187-210.

  14. 14.

    Tomar S L, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000; 71: 743-751.

  15. 15.

    Faddy M J, Cullinan M P, Palmer J E, Westerman B, Seymour G J. Ante-dependence modeling in a longitudinal study of periodontal disease: the effect of age, gender, and smoking status. J Periodontol 2000; 71: 454-459.

  16. 16.

    Labriola A, Needleman I, Moles D R. Systematic review of the effect of smoking on nonsurgical periodontal therapy. Periodontol 2000 2005; 37: 124-137.

  17. 17.

    Kotsakis G A, Javed F, Hinrichs J E, Karoussis I K, Romanos G E. Impact of cigarette smoking on clinical outcomes of periodontal flap surgical procedures: a systematic review and meta-analysis. J Periodontol 2015; 86: 254-263.

  18. 18.

    Patel R A, Wilson R F, Palmer R M. The effect of smoking on periodontal bone regeneration: a systematic review and meta-analysis. J Periodontol 2012; 83: 143-155.

  19. 19.

    Gravely S, Fong G T, Cummings K M et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: Findings from the ITC project. Int J Environ Res Public Health 2014; 11: 11691-11704.

  20. 20.

    Smoking in England. Available at: http: //www.smokinginengland.info/latest-statistics/. Accessed: 02/06/2019: 2019.

  21. 21.

    Breland A, Soule E, Lopez A, Ramoa C, El-Hellani A, Eissenberg T. Electronic cigarettes: what are they and what do they do? Ann N Y Acad Sci 2017; 1394: 5-30.

  22. 22.

    Wadia R, Booth V, Yap H F, Moyes D L. A pilot study of the gingival response when smokers switch from smoking to vaping. Br Dent J 2016; 221: 722-726.

  23. 23.

    Nicotine without smoke. In Tobacco harm reduction. London: Royal College of Physicians, 2016.

  24. 24.

    Ramoa C P, Eissenberg T, Sahingur S E. Increasing popularity of waterpipe tobacco smoking and electronic cigarette use: Implications for oral healthcare. J Periodontal Res 2017; 52: 813-823.

  25. 25.

    Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead L F, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016; CD010216.

  26. 26.

    Hajek P, Phillips-Waller A, Przulj D et al. A randomized trial of ecigarettes versus nicotine-replacement therapy. New Engl J Med 2019; 380: 629-637.

  27. 27.

    NICE NIfHaCE. Stop smoking interventions and services. National Institute for Health and Care Excellence, 2018.

  28. 28.

    Salvi G E, Carollo-Bittel B, Lang N P. Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. J Clin Periodontol 2008; 35: 398-409.

  29. 29.

    Salvi G E, Kandylaki M, Troendle A, Persson G R, Lang N P. Experimental gingivitis in type 1 diabetics: a controlled clinical and microbiological study. J Clin Periodontol 2005; 32: 310-316.

  30. 30.

    Tsai C, Hayes C, Taylor G W. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192.

  31. 31.

    Taylor G W, Burt B A, Becker M P, Genco R J, Shlossman M. Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 1998; 3: 30-39.

  32. 32.

    Chapple I L, Genco R. Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013; 84: S106-112.

  33. 33.

    Taylor J J, Preshaw P M, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013; 40 (Suppl 14): S113-134.

  34. 34.

    Knight E T, Liu J, Seymour G J, Faggion C M, Jr., Cullinan M P. Risk factors that may modify the innate and adaptive immune responses in periodontal diseases. Periodontol 2000 2016; 71: 22-51.

  35. 35.

    Bissett S M, Presseau J, Rapley T, Preshaw P M. Uptake of best practice recommendations in the management of patients with diabetes and periodontitis: a cross-sectional survey of dental clinicians. Br Dent J 2019.

  36. 36.

    Wimmer G, Kohldorfer G, Mischak I, Lorenzoni M, Kallus K W. Coping with stress: its influence on periodontal therapy. J Periodontol 2005; 76: 90-98.

  37. 37.

    D'Aiuto F, Gkranias N, Bhowruth D et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol 2018; 6: 954-965.

  38. 38.

    D'Aiuto F, Orlandi M, Gunsolley J C. Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol 2013; 40 (Suppl 14): S85-105.

  39. 39.

    Periodontology TBSo. In The good practitioner's guide to periodontology. England: The British Society of Periodontology, 2016.

  40. 40.

    Engebretson S, Kocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Periodontol 2013; 84: S153-169.

  41. 41.

    Otomo-Corgel J. Dental management of the female patient. Periodontol 2000 2013; 61: 219-231.

  42. 42.

    Gonzalez-Jaranay M, Tellez L, Roa-Lopez A, Gomez-Moreno G, Moreu G. Periodontal status during pregnancy and postpartum. PloS One 2017; 12: e0178234.

  43. 43.

    Corbella S, Taschieri S, Del Fabbro M, Francetti L, Weinstein R, Ferrazzi E. Adverse pregnancy outcomes and periodontitis: A systematic review and meta-analysis exploring potential association. Quintessence International (Berlin, Germany: 1985) 2016; 47: 193-204.

  44. 44.

    Iheozor-Ejiofor Z, Middleton P, Esposito M, Glenny A M. Treating periodontal disease for preventing adverse birth outcomes in pregnant women. Cochrane Database Syst Rev 2017; 6: CD005297.

  45. 45.

    Sanz M, Kornman K. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013; 84: S164-169.

  46. 46.

    Seymour RA. Effects of medications on the periodontal tissues in health and disease. Periodontol 2000 2006; 40: 120-129.

  47. 47.

    Seymour R A, Ellis J S, Thomason J M. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000; 27: 217-223.

  48. 48.

    Pernu H E, Pernu L M, Knuuttila M L. Effect of periodontal treatment on gingival overgrowth among cyclosporine Atreated renal transplant recipients. J Periodontol 1993; 64: 1098-1100.

  49. 49.

    Somacarrera M L, Hernandez G, Acero J, Moskow B S. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994; 65: 671-675.

  50. 50.

    Preshaw P M. Oral contraceptives and the periodontium. Periodontol 2000 2013; 61: 125-159.

  51. 51.

    Sutton R B, Smales F C. Cross-sectional study of the effects of immunosuppressive drugs on chronic periodontal disease in man. J Clin Periodontol 1983; 10: 317-326.

  52. 52.

    Tollefsen T, Koppang H S, Messelt E. Immunosuppression and periodontal disease in man. Histological and ultrastructural observations. J Periodontal Res 1982; 17: 329-344.

  53. 53.

    Alani A, Seymour R. Systemic medication and the inflammatory cascade. Periodontol 2000 2014; 64: 198-210.

  54. 54.

    Schmalz G, Berisha L, Wendorff H et al. Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation. Medicina oral, patologia oral y cirugia bucal 2018; 23: e326-e334.

  55. 55.

    Kinane D F. Periodontitis modified by systemic factors. Ann Periodontol 1999; 4: 54-64.

  56. 56.

    Holmstrup P, Glick M. Treatment of periodontal disease in the immunodeficient patient. Periodontol 2000 2002; 28: 190-205.

  57. 57.

    Meyer U, Kleinheinz J, Handschel J, Kruse-Losler B, Weingart D, Joos U. Oral findings in three different groups of immunocompromised patients. J Oral Pathol Med 2000; 29: 153-158.

  58. 58.

    Ryder MI. Periodontal management of HIV-infected patients. Periodontol 2000 2000; 23: 85-93.

  59. 59.

    Swango P A, Kleinman D V, Konzelman J L. HIV and periodontal health. A study of military personnel with HIV. J Am Dent Assoc 1991; 122: 49-54.

  60. 60.

    Peruzzo D C, Benatti B B, Ambrosano G M et al. A systematic review of stress and psychological factors as possible risk factors for periodontal disease. J Periodontol 2007; 78: 1491-1504.

  61. 61.

    Axtelius B, Soderfeldt B, Nilsson A, Edwardsson S, Attstrom R. Therapy-resistant periodontitis. Psychosocial characteristics. J Clin Periodontol 1998; 25: 482-491.

  62. 62.

    Kaye E K. Nutrition, dietary guidelines and optimal periodontal health. Periodontol 2000 2012; 58: 93-111.

  63. 63.

    Chapple I L, Milward M R, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr 2007; 137: 657-664.

  64. 64.

    Ceriello A, Esposito K, Piconi L et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57: 1349-1354.

  65. 65.

    Sidi A D, Ashley F P. Influence of frequent sugar intakes on experimental gingivitis. J Periodontol 1984; 55: 419-423.

  66. 66.

    Baumgartner S, Imfeld T, Schicht O, Rath C, Persson R E, Persson G R. The impact of the stone age diet on gingival conditions in the absence of oral hygiene. J Periodontol 2009; 80: 759-768.

  67. 67.

    Van der Velden U, Kuzmanova D, Chapple I L. Micronutritional approaches to periodontal therapy. J Clin Periodontol 2011; 38 (Suppl 11): 142-158.

  68. 68.

    Reynolds M A. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol 2000 2014; 64: 7-19.

  69. 69.

    NICE NIfHaCE. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. National Institute for Health and Care Excellence, 2011.

  70. 70.

    Klassen J T, Krasko B M. The dental health status of dialysis patients. J Can Dent Assoc 2002; 68: 34-38.

  71. 71.

    Silverman S, Jr, Ware W H, Gillooly C, Jr. Dental aspects of hyperparathyroidism. Oral Surg Oral Med Oral Pathol 1968; 26: 184-189.

  72. 72.

    Frankenthal S, Nakhoul F, Machtei E E et al. The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium. J Clin Periodontol 2002; 29: 479-483.

  73. 73.

    Padbury A D, Jr, Tozum T F, Taba M, Jr et al. The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab 2006; 91: 3439-3445.

  74. 74.

    Reddy M S, Morgan S L. Decreased bone mineral density and periodontal management. Periodontol 2000 2013; 61: 195-218.

  75. 75.

    Brennan-Calanan R M, Genco R J, Wilding G E, Hovey K M, Trevisan M, Wactawski-Wende J. Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res 2008; 87: 323-327.

  76. 76.

    Reyes L, Herrera D, Kozarov E, Roldan S, Progulske-Fox A. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Clin Periodontol 2013; 40 (Suppl 14): S30-50.

  77. 77.

    Dietrich T, Sharma P, Walter C, Weston P, Beck J. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J Clin Periodontol 2013; 40 (Suppl 14): S70-84.

  78. 78.

    Tonetti M S, Van Dyke T E, Working group 1 of the joint EFPAAPw. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol 2013; 40 (Suppl 14): S24-29.

  79. 79.

    Li C, Lv Z, Shi Z et al. Periodontal therapy for the management of cardiovascular disease in patients with chronic periodontitis. Cochrane Database Syst Rev 2017; CD009197.

  80. 80.

    de Castilhos E D, Horta B L, Gigante D P, Demarco F F, Peres K G, Peres M A. Association between obesity and periodontal disease in young adults: a population-based birth cohort. J Clin Periodontol 2012; 39: 717-724.

  81. 81.

    Amin Hel S. Relationship between overall and abdominal obesity and periodontal disease among young adults. East Mediterr Health J 2010; 16: 429-433.

  82. 82.

    Keller A, Rohde J F, Raymond K, Heitmann B L. Association between periodontal disease and overweight and obesity: a systematic review. J Periodontol 2015; 86: 766-776.

  83. 83.

    Lee J H, Oh J Y, Youk T M, Jeong S N, Kim Y T, Choi S H. Association between periodontal disease and non-communicable diseases: A 12-year longitudinal health-examinee cohort study in South Korea. Medicine (Baltimore) 2017; 96: e7398.

  84. 84.

    Moura-Grec P G, Marsicano J A, Carvalho C A, Sales-Peres S H. Obesity and periodontitis: systematic review and meta-analysis. Cien Saude Colet 2014; 19: 1763-1772.

  85. 85.

    Suvan J E, Petrie A, Nibali L et al. Association between overweight/obesity and increased risk of periodontitis. J Clin Periodontol 2015.

  86. 86.

    Papageorgiou S N, Reichert C, Jager A, Deschner J. Effect of overweight/obesity on response to periodontal treatment: systematic review and a meta-analysis. J Clin Periodontol 2015; 42: 247-261.

  87. 87.

    Gerber F A, Sahrmann P, Schmidlin O A, Heumann C, Beer J H, Schmidlin P R. Influence of obesity on the outcome of non-surgical periodontal therapy - a systematic review. BMC Oral Health 2016; 16: 90.

Download references

Author information



Corresponding author

Correspondence to Amardip S. Kalsi.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kalsi, A., Bomfim, D. & Hussain, Z. Factors affecting decision making at reassessment of periodontitis. Part 2: interpretation of clinical findings - systemic factors. Br Dent J 227, 797–801 (2019). https://doi.org/10.1038/s41415-019-0893-3

Download citation


Quick links